Shang YM - Search Results

1

Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma.

Zhao L, Yang Y, Ma B, Li W, Li T, Han L, Zhang Y, Shang YM, Lin H, Gao Q. Zhao L, et al. Among authors: shang ym. J Oncol. 2019 Sep 26;2019:6454989. doi: 10.1155/2019/6454989. eCollection 2019. J Oncol. 2019. PMID: 31662753 Free PMC article.

2

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.

Wang Z, Liu Y, Li R, Shang Y, Zhang Y, Zhao L, Li W, Yang Y, Zhang X, Yang T, Nie C, Han F, Liu Y, Luo S, Gao Q, Song Y. Wang Z, et al. J Hematol Oncol. 2016 Feb 3;9:6. doi: 10.1186/s13045-016-0237-6. J Hematol Oncol. 2016. PMID: 26842696 Free PMC article.

3

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer.

Ma B, Zhou Y, Shang Y, Zhang Y, Xu B, Fu X, Guo J, Yang Y, Zhang F, Zhou M, Huang H, Li F, Lin H, Zhao L, Wang Z, Gao Q. Ma B, et al. Front Oncol. 2022 Sep 9;12:852885. doi: 10.3389/fonc.2022.852885. eCollection 2022. Front Oncol. 2022. PMID: 36158690 Free PMC article.

4

Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.

Han L, Shang YM, Song YP, Gao QL. Han L, et al. Among authors: shang ym. J Immunol Res. 2016;2016:5706814. doi: 10.1155/2016/5706814. Epub 2016 Jun 28. J Immunol Res. 2016. PMID: 27433478 Free PMC article.

5

T Cells Expanded from PD-1⁺ Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating Lymphocytes.

Li T, Zhao L, Yang Y, Wang Y, Zhang Y, Guo J, Chen G, Qin P, Xu B, Ma B, Zhang F, Shang Y, Li Q, Zhang K, Yuan D, Feng C, Ma Y, Liu Z, Tian Z, Li H, Wang S, Gao Q. Li T, et al. Cancer Res. 2021 Apr 15;81(8):2184-2194. doi: 10.1158/0008-5472.CAN-20-2300. Epub 2021 Jan 6. Cancer Res. 2021. PMID: 33408117

6

MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.

Wang Z, Liu Y, Zhang Y, Shang Y, Gao Q. Wang Z, et al. Oncotarget. 2016 Jan 26;7(4):4760-9. doi: 10.18632/oncotarget.6734. Oncotarget. 2016. PMID: 26716894 Free PMC article.

7

Platelet-to-lymphocyte ratio in peripheral blood: A novel independent prognostic factor in patients with melanoma.

Qi Y, Zhang Y, Fu X, Wang A, Yang Y, Shang Y, Gao Q. Qi Y, et al. Int Immunopharmacol. 2018 Mar;56:143-147. doi: 10.1016/j.intimp.2018.01.019. Epub 2018 Feb 3. Int Immunopharmacol. 2018. PMID: 29414644

8

Survival benefit from RectroNectin-activated cytokine-induced killer cells combined with chemotherapy in advanced EGFR wild-type lung adenocarcinoma.

Zhao L, Li W, Wang Z, Yang Y, Zhang Y, Shang Y, Ren X, Gao Q. Zhao L, et al. Immunotherapy. 2018 Mar 1;10(6):501-510. doi: 10.2217/imt-2017-0140. Immunotherapy. 2018. PMID: 29562855

9

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer.

Fu X, Zhang Y, Yang J, Qi Y, Ming Y, Sun M, Shang Y, Yang Y, Zhu X, Gao Q. Fu X, et al. Onco Targets Ther. 2018 Sep 20;11:6091-6100. doi: 10.2147/OTT.S174138. eCollection 2018. Onco Targets Ther. 2018. PMID: 30275713 Free PMC article.

10

Combination of PD-1 blockade and RetroNectin^®-activated cytokine-induced killer in preheavily treated non-small-cell lung cancer: a retrospective study.

Zhao L, Han L, Zhang Y, Li T, Yang Y, Li W, Shang Y, Lin H, Gao Q. Zhao L, et al. Immunotherapy. 2018 Nov;10(15):1315-1323. doi: 10.2217/imt-2018-0125. Epub 2018 Oct 23. Immunotherapy. 2018. PMID: 30350739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters